Inheritance, innovation and development of traditional Chinese medicine in new era call for scientific supervision.
10.19540/j.cnki.cjcmm.20221021.601
- Author:
Ming HUANG
1
;
Feng-Wen YANG
1
;
Jun-Hua ZHANG
1
;
Bo-Li ZHANG
2
Author Information
1. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China Key Laboratory of Evidence-based Evaluation of Traditional Chinese Medicine,National Medical Products Administration Tianjin 301617, China.
2. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
- Publication Type:Journal Article
- Keywords:
modernization of traditional Chinese medicine;
scientific supervision;
traditional Chinese medicine
- MeSH:
Humans;
Medicine, Chinese Traditional;
Drugs, Chinese Herbal/therapeutic use*;
Pharmaceutical Preparations;
Reference Standards
- From:
China Journal of Chinese Materia Medica
2023;48(1):1-4
- CountryChina
- Language:Chinese
-
Abstract:
Pharmaceutical products need to ensure the effectiveness, safety and quality controllability through scientific supervision, and as the broad masses of the people are full of new expectations for the supply of high-quality traditional Chinese medicine products, the reform and innovation of traditional Chinese medicine regulatory policies are also facing new opportunities and new challenges. National Medical Products Administration, National Administration of Traditional Chinese Medicine and other relevant departments have implemented the requirements of the Party Central Committee and the State Council, vigorously promoted the reform of the regulatory system in line with the characteristics of traditional Chinese medicine, introduced a series of innovative policies, and achieved phased results. Including the new registration classification standards in line with the characteristics of traditional Chinese medicine, encouraging the development of classical formulas and hospital preparations, encouraging the research and development of symptomatic Chinese medicines, and gra-dually improving the "three-combined " evidence system. However, in the face of the development problems of traditional Chinese medicine in the new era, it is still necessary to improve the scientific supervision system, further optimize the management measures for the registration of traditional Chinese medicines based on classical formulas, accelerate the improvement of the standard system for traditional Chinese medicine formula granules, and form management measures to encourage and support the secondary development of traditional Chinese medicines. In terms of scientific supervision of traditional Chinese medicine, it is necessary to follow the characteristics and development laws of traditional Chinese medicine itself, comprehensively consider the characteristics of epochal, scientific and systematic in regulatory policies, and serve the inheritance and innovative development of traditional Chinese medicine with scientific supervision.
